I see Jason Napodano is now pumping another compa
Post# of 30028
"The company is also developing an AD diagnostic test with early results showing sensitivity (correctly diagnosing AD) = 97% and specificity (correctly identifying individuals without AD) = 96%."
http://seekingalpha.com/article/2575735-neuro...-mechanism